Pulmonx Corp — Director's Dealing 2021

Dec 4, 2021

SEC Form 4/A — Form 4/A

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-04-15

Reporting Person: French Glendon E. III (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-15	Common Stock	M	25000	$2.20	Acquired	1274884	Direct
2021-04-15	Common Stock	S	19989	$43.64	Disposed	1254895	Direct
2021-04-15	Common Stock	S	5011	$44.21	Disposed	1249884	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-15	Stock Option (Right to Buy)	$2.20	M	25000	Disposed	2030-08-27	Common Stock (25000)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.12 to $44.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.13 to $44.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on August 28, 2020, subject to the Reporting Person's continuous service through each such vesting date.